NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
ID: 343045Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/343045

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-028.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)." This initiative aims to support exploratory and developmental clinical research projects that investigate the effects of structural racism on neurocognition and the risk of substance use disorders (SUD), emphasizing innovative approaches that consider both structural and biological factors. The program is designed to promote health equity and reduce disparities among racial and ethnic minority populations, with funding available up to $1.5 million annually for 3-5 projects, each with a budget cap of $500,000 per year. Interested applicants must submit proposals by November 14, 2024, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    RFA-DA-23-028-Full-Announcement.html
    RFA-DA-23-028.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a Funding Opportunity Announcement (FOA) entitled "NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)." This initiative aims to support exploratory and developmental clinical research projects that explore the effects of structural racism on neurocognition and substance use disorder (SUD) risk. The emphasis is on innovative, multidimensional approaches that investigate the interplay between structural and biological factors affecting substance use trajectories. The funding opportunity offers up to $1.5 million annually to fund 3-5 research projects, with budgets not exceeding $500,000 per year. A phased award mechanism will support projects for a maximum of five years, including an initial two-year phase followed by a three-year extension based on milestone achievements. Eligible applicants include various educational institutions and organizations interested in addressing health disparities related to SUD through community-engaged research that promotes racial equity. The initiative aligns with NIH's commitment to advance health equity and reduce health disparities, particularly among racial and ethnic minority populations.
    Similar Opportunities
    NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory." This initiative aims to support exploratory research that investigates the neurocognitive effects of structural racism on substance use disorders, particularly within minority-serving institutions, and encourages interdisciplinary approaches to develop preventive strategies against health disparities. The program offers a phased funding mechanism (R61/R33) with a total commitment of $1.5 million annually, aiming to fund 3-5 awards per year, with applications due by November 14, 2024. For further inquiries, applicants can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the opportunity's webpage for more details.
    NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research," aimed at supporting R01 applications that focus on community-partnered research to mitigate disparities in substance misuse and health outcomes among racial and ethnic minority populations. This initiative emphasizes the establishment of collaborative community partnerships to ensure that research addresses immediate community needs and employs effective methodologies, thereby advancing health equity in the context of substance use and addiction. The program has a budget of approximately $2 million for FY 2023, with applications due by November 14, 2024. Interested applicants can find more information and application instructions at the provided link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions." This initiative invites R01 applications aimed at conducting impactful research to address disparities in substance use and addiction outcomes among racial and ethnic minority populations, emphasizing community engagement and collaboration with community organizations. The program is part of NIDA's broader Racial Equity Initiative, which seeks to improve health equity and reduce health disparities, with approximately $2 million anticipated for funding across multiple related announcements. Interested applicants, particularly from minority-serving institutions, must submit proposals by November 14, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity, aimed at supporting innovative research that addresses disparities in substance use among underserved racial and ethnic minority groups in the U.S. This initiative invites applications from early career or established scholars who propose high-impact projects that challenge existing paradigms and foster community engagement to tackle systemic factors impacting health disparities. With a funding commitment of approximately $2 million annually for 2-3 awards, applicants can request up to $700,000 in direct costs per year for a maximum project period of five years. Interested applicants should submit their proposals by November 14, 2024, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov. For more details, visit the official announcement at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html.
    NIDA REI: Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering the Racial Equity Visionary Award Program to support innovative research addressing substance use disparities among underserved racial and ethnic minority groups. This funding opportunity invites early career and established scholars from domestic minority-serving institutions to submit proposals that challenge existing scientific paradigms and aim for transformative impacts in health equity. NIDA plans to allocate approximately $2 million annually for 2-3 awards, with each application budget capped at $700,000 for projects lasting up to five years. Interested applicants must adhere to NIH guidelines and submit their proposals by November 14, 2024, with further inquiries directed to OERWebmaster03@od.nih.gov.
    NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use," aimed at addressing HIV-related health disparities in underserved racial and ethnic populations. This initiative seeks to stimulate research that explores structural, organizational, and contextual factors contributing to these inequities, with a focus on complex identities and social systems affecting marginalized communities. A total funding pool of $3 million is anticipated for 5-9 awards, with applications due by November 14, 2024. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities," aimed at supporting intervention research to improve health outcomes among minority populations affected by health disparities. The initiative seeks projects that investigate the influence of structural racism and discrimination on health determinants, promote multidisciplinary collaboration, and utilize diverse data sources for comprehensive analysis. With a funding ceiling of $500,000, the application deadline is set for January 7, 2026, and interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Exploratory Clinical Neuroscience Research on Substance Use Disorders" (R61/R33), aimed at supporting innovative clinical research that explores the neurobiological mechanisms underlying substance use disorders (SUD). This initiative encourages applications that investigate neural circuitry and cognitive processes affecting substance use behavior, particularly in the context of the ongoing public health crisis related to SUDs, including the opioid epidemic. The R61/R33 mechanism allows for up to five years of funding, divided into an initial two-year R61 phase and a potential three-year R33 phase, contingent upon meeting specified milestones. Interested applicants can find more information and submit proposals by the application due date of March 13, 2026, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the R34 Planning Grant under its Racial Equity Initiative (REI), aimed at addressing HIV-related health disparities among underserved racial and ethnic populations. This funding opportunity supports pilot or feasibility research that explores the social, structural, and contextual factors contributing to inequities at the intersection of HIV and substance use, while encouraging projects that consider individuals' multidimensional identities. The initiative is critical in promoting health equity and aligns with the HHS's goal of ending the HIV epidemic by 2030, with a total budget of $3 million available to fund 5 to 9 projects, each with direct cost requests up to $450,000 over three years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by November 14, 2024.
    Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for exploratory clinical neuroscience research focused on substance use disorders (SUD) through the R61/R33 phased innovation award mechanism. This funding opportunity aims to support clinical research proposals that investigate the neurobiological mechanisms underlying SUD, allowing for up to five years of funding, with the R61 phase dedicated to initial concept testing and the R33 phase contingent upon achieving specific milestones. The initiative is crucial for advancing understanding of substance abuse impacts in the U.S., encouraging innovative research on topics such as neural circuitry and cognitive factors influencing addiction. Interested applicants, including various educational and nonprofit institutions, can find more details and submit applications by the closing date of May 7, 2026, with no cost-sharing requirement. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-158.html.